Live Breaking News & Updates on Institutional Perspectives

Stay updated with breaking news from Institutional perspectives. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Cobain on the Importance of Molecular Testing in Metastatic Breast Cancer

Dr Cobain on the Importance of Molecular Testing in Metastatic Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United States , Erin Frances Cobain , Breast Cancer Clinical Research Team , Rogel Cancer Center , University Of Michigan , Institutional Perspectives ,

Garmezy Highlights Ongoing and Future Research Directions Across RCC Subtypes

Benjamin Garmezy, MD, provides an overview of recent data on immuno-oncology/TKI combination data in variant renal cell carcinoma. ....

United States , Benjamin Garmezy , Genitourinary Research At Sarah Cannon Institute , Institutional Perspectives , Genitourinary Research , Sarah Cannon Research Institute , Tennessee Oncology , Genitourinary Cancers , Renal Cell Carcinoma ,

Individualized Approach Best Informs Choice of Frontline Immunotherapy or Targeted Therapy Combinations Across RCC Histologies

Benjamin Garmezy, MD, discusses challenges associated with navigating the current frontline armamentarium in both clear cell and variant RCC, the impact of frontline IO doublets and IO/TKI regimens on patient outcomes, and the importance of ongoing combination studies for patients with variant RCC. ....

United States , Benjamin Garmezy , Genitourinary Research , Sarah Cannon Research Institute , Tennessee Oncology , Institutional Perspectives , Sarah Cannon Research Institute At Tennessee Oncology , Onclive Tv , Immunotherapy In Gu Cancers , Gu Cancers ,

Continued Investigations are Pertinent for FDA Approvals in the Treatment of Patients With EGFR-mutated NSCLC

Jason Porter, MD, highlights the implications of recent data to emerge following the use of EGFR TKIs in the adjuvant setting, the importance of the potential upcoming FDA approval of osimertinib with chemotherapy in EGFR-positive non–small cell lung cancer, and more. ....

United States , Wadet Iams , Danielv Wakefield , Erina Gillaspie , Nagla Abdel Karim , Jason Porter , Vanderbilt Ingram Cancer Center , Research Institute In Memphis , University Of Virginia , Institutional Perspectives , Lung Cancer Disease Research Group , West Cancer Center , Research Institute , Egfr Tkis , Adaura Trial , Institutional Perspectives In Cancer , Egfr Mutations , Non Small Cell Lung Cancer ,

Sequencing BCMA-Directed Therapies Expands Multiple Myeloma Treatment Horizons

Sikander Ailawadhi, MD, spotlights the characteristics of multiple myeloma that drive the decision to use teclistamab-cqyv, elranatamab-bcmm, or talquetamab-tgvs. ....

United States , Sikander Ailawadhi , National Cancer Institute , Mayo Clinic , Institutional Perspectives , African American , Onclive Institutional Perspectives In Cancer , Multiple Myeloma ,